A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia
- 1 August 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (8) , 1292-1308
- https://doi.org/10.1016/s0149-2918(02)80034-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Monotherapy May Be Suboptimal for Severe Bacteremic Pneumococcal PneumoniaArchives of internal medicine (1960), 2001
- Bacteremic Pneumonia Due to Multidrug-Resistant Pneumococci in 3 Patients Treated Unsuccessfully with Azithromycin and Successfully with LevofloxacinClinical Infectious Diseases, 2000
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Severe community-acquired pneumococcal pneumonia -- what might be done better.Intensive Care Medicine, 1999
- Severe Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- COMMUNITY-ACQUIRED PNEUMONIA: EPIDEMIOLOGY, ETIOLOGY, TREATMENTInfectious Disease Clinics of North America, 1998
- Severe Community-Acquired PneumoniaAnaesthesia and Intensive Care, 1997
- Etiology and Therapy of Community-Acquired PneumoniaJournal of Chemotherapy, 1997
- Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysisJAMA, 1996
- A Comparison of Large-Sample Confidence Interval Methods for the Difference of Two Binomial ProbabilitiesThe American Statistician, 1986